CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 89 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,354,000 | +0.9% | 112,204 | +5.0% | 0.00% | 0.0% |
| Q4 2018 | $1,342,000 | -66.7% | 106,904 | -60.6% | 0.00% | 0.0% |
| Q3 2018 | $4,024,000 | +35.0% | 271,198 | +53.1% | 0.00% | -50.0% |
| Q2 2018 | $2,981,000 | -7.9% | 177,099 | +25.3% | 0.00% | 0.0% |
| Q1 2018 | $3,236,000 | -27.9% | 141,312 | -18.5% | 0.00% | -33.3% |
| Q4 2017 | $4,487,000 | +173.8% | 173,457 | +56.1% | 0.00% | +200.0% |
| Q3 2017 | $1,639,000 | -9.5% | 111,114 | -14.4% | 0.00% | 0.0% |
| Q2 2017 | $1,811,000 | -15.2% | 129,819 | +3.7% | 0.00% | -50.0% |
| Q1 2017 | $2,136,000 | +95.6% | 125,183 | +18.0% | 0.00% | +100.0% |
| Q4 2016 | $1,092,000 | +3.3% | 106,105 | +1.5% | 0.00% | 0.0% |
| Q3 2016 | $1,057,000 | -11.5% | 104,547 | -1.7% | 0.00% | 0.0% |
| Q2 2016 | $1,195,000 | -16.7% | 106,406 | +1.3% | 0.00% | 0.0% |
| Q1 2016 | $1,435,000 | -26.7% | 105,016 | +1.8% | 0.00% | 0.0% |
| Q4 2015 | $1,957,000 | +28.3% | 103,170 | +26.9% | 0.00% | 0.0% |
| Q3 2015 | $1,525,000 | +535.4% | 81,270 | +405.0% | 0.00% | – |
| Q2 2015 | $240,000 | +500.0% | 16,093 | +403.5% | 0.00% | – |
| Q3 2014 | $40,000 | -88.2% | 3,196 | -90.5% | 0.00% | – |
| Q2 2014 | $340,000 | -0.3% | 33,696 | +32.8% | 0.00% | – |
| Q1 2014 | $341,000 | – | 25,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |